The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The objective of this study is to prove the safety and efficacy of the Lumax 740 ICD family. Primarily, the newly implemented RV/LV Capture Control algorithm is evaluated, which automatically measures the RV/LV threshold and subsequently adjusts the pacing output.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with standard ICD indication who are referred to the hospital.
Inclusion Criteria: Standard indication for single, dual, or triple chamber ICD.
Legal capacity and ability to consent
Signed patient informed consent
In addition for HF-T devices:
Bipolar LV-lead with a min. distance of 15 mm between tip and ring
True bipolar RV lead
Standard contraindication for single, dual, or triple chamber ICD.
Age < 18 years
Pregnant or breast-feeding woman
Cardiac surgery planned within the next 6 months
Life expectancy of less than 6 months
Participating in any other clinical study of an investigational cardiac drug or device